Standout Papers

Dasatinib in Imatinib-Resistant Philadelphia Chromosome–Positive Leukemias 2006 2026 2012 2019 1.5k
  1. Dasatinib in Imatinib-Resistant Philadelphia Chromosome–Positive Leukemias (2006)
    Moshe Talpaz, Neil P. Shah et al. New England Journal of Medicine
  2. Pooled Analysis of Long-Term Survival Data From Phase II and Phase III Trials of Ipilimumab in Unresectable or Metastatic Melanoma (2015)
    Dirk Schadendorf, F. Stephen Hodi et al. Journal of Clinical Oncology

Immediate Impact

28 by Nobel laureates 9 from Science/Nature 97 standout
Sub-graph 1 of 15

Citing Papers

Colorectal cancer
2024 Standout
Immune checkpoint therapy—current perspectives and future directions
2023 StandoutNobel
15 intermediate papers

Works of Tai‐Tsang Chen being referenced

Pooled Analysis of Long-Term Survival Data From Phase II and Phase III Trials of Ipilimumab in Unresectable or Metastatic Melanoma
2015 Standout
Ipilimumab efficacy and safety in patients with advanced melanoma: a retrospective analysis of HLA subtype from four trials.
2010
and 3 more

Author Peers

Author Last Decade Papers Cites
Tai‐Tsang Chen 2560 342 202 1243 1141 37 4.3k
Lewis C. Strauss 1140 213 8 798 1507 62 3.8k
Robert Ilaria 1079 190 13 413 1248 57 3.1k
Pieter A. van der Velden 1679 861 1 990 2860 84 6.8k
Cyrus V. Hedvat 1703 1172 4 852 1273 75 5.3k
Hans D. Menssen 1026 169 8 517 1903 62 3.4k
Owen N. Witte 925 452 2 736 555 46 3.0k
Siddhartha Jaiswal 1335 896 2928 2670 52 6.7k
Philippe Martiat 1301 1473 23 916 1520 109 5.5k
Juerg Schwaller 1192 311 3 745 1287 65 3.8k
David R. Stover 1101 184 398 945 46 3.0k

All Works

Loading papers...

Rankless by CCL
2026